The understanding of the molecular basis of regulation of NRG-1/ErbB pathway and L-arginine involvement will facilitate the design of new therapeutic strategies to potentiate muscle survival and regeneration in DMD patients. Here, NRG1 is linked to Duchenne muscular dystrophy.